Annual report pursuant to Section 13 and 15(d)

Consolidated Balance Sheets

v3.21.2
Consolidated Balance Sheets - USD ($)
$ in Thousands
Jun. 30, 2021
Jun. 30, 2020
Assets:    
Cash and cash equivalents $ 88,322 $ 44,308
Accounts receivable 1,170 351
Inventory 1,390 136
Other current assets 2,314 1,408
Total current assets 93,196 46,203
Property and equipment, net 30,730 23,605
Intangibles, net 572 544
Operating lease right-of-use asset, net 471 699
Restricted cash 100
Other assets 25 282
Total Assets 124,994 71,433
Current Liabilities:    
Accounts payable and accrued expenses 6,954 5,899
Operating lease liability-current 270 231
Deferred revenue 41
Total current liabilities 7,265 6,130
Long-term Liabilities:    
Convertible notes payable, net 21,628
Operating lease liability-non current 202 472
Loans payable 1,591
Other long-term liabilities 117 117
Total long-term liabilities 319 23,808
Total Liabilities 7,584 29,938
Stockholders’ Equity    
Preferred Stock, par value $0.001: 5,000,000 shares authorized; none issued and outstanding
Common stock, $0.001 par value; 100,000,000 shares authorized; 51,235,764 and 37,990,380 shares issued and outstanding at June 30, 2021 and June 30, 2020, respectively 51 38
Additional paid in capital 265,130 145,072
Accumulated deficit (147,771) (103,615)
Total Stockholders’ Equity 117,410 41,495
Total Liabilities and Stockholders’ Equity $ 124,994 $ 71,433